Search form

Sections

Carl Elliott

Slap: American Journal of Bioethics Goes On Offense During Painkiller Inquiry

Antidote has received some disturbing communications from a bioethics journal we reported on. Read on for the back story.

Q&A with Leigh Turner, Part 3: Celltex Tries to Intimidate a Whistleblower

Bioethicist Leigh Turner describes how the stem cell company Celltex tried to intimidate him and his university when he asked the FDA to investigate the company.

Q&A with Leigh Turner, Part 2: Finding Ethical Quandaries Amid Academic Rivalries

Bioethicist Leigh Turner talks about why he sicced the FDA on Celltex and about academic rivalries in the world of bioethics.

Q&A with Leigh Turner: Tracking Medical Tourism Consequences

Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.

Slap: Celltex Threatens University of Minnesota For Ethicist's FDA Letter

When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.

Slap: Pressure From Politically-Connected Stem Cell Firm Celltex Leads To Slate Retraction

Why did Slate retract a critical commentary by bioethicist Carl Elliott on stem cell firm Celltex after a demand by the controversial company's CEO?

The Markingson Files: Court leaves key questions in clinical trial suicide unanswered

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

The Markingson Files: University of Minnesota dallies on clinical trial documentation

A candid email from a university publicist sheds some, but not enough, light on why the university won't provide documents from a controversial Seroquel clinical study.

The Markingson Files: Conflicts of interest in clinical trials should be transparent

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

The Markingson Files: Why health writers should track the money behind medical studies

One of the biggest oversights a health writer can make is to cover a scientific study and not talk about its funders. William Heisel examines what can happen when a study's funding is overlooked.

Pages

Announcements

Since the passage of the ACA, hospital consolidation has dramatically increased. Our webinar will give an overview of this trend, clarify what’s at stake for consumers, and give journalists fresh ideas for reporting in new, incisive ways. Our panel will include experts Martin Gaynor and Paul Ginsburg, as well as NYT’s Margot Sanger-Katz. More info here.

CONNECT WITH THE COMMUNITY

Member Activities

William Heisel has shared a blog post

Read it.

SE Ruckman's profile has been updated

Connect with SE Ruckman

Sally James's profile has been updated

Connect with Sally James

Frieda Wiley joined the community

Connect with Frieda Wiley

Daniel Chang has shared a fellowship project

Read it.
More Member Activities

Follow Us

ReportingHealth

Reporting on Underserved Communities



How can journalists and foundations collaborate to deepen and improve reporting on underserved communities? Our USC Annenberg School of Journalism program in collaboration with The California Endowment, the Wyncote Foundation and Media Impact Funders, convened 75 leaders from both fields.

Read More »